Manrai Manish, Singh Anupam K, Birda Chhagan Lal, Shah Jimil, Dutta Aditya, Bhadada Sanjay Kumar, Kochhar Rakesh
Department of Internal Medicine, Armed Forces Medical College, Pune 411040, Maharashtra, India.
Department of Gastroenterology, Postgraduate Institute of Medical Education and Research, Chandigarh 160012, India.
World J Diabetes. 2023 Aug 15;14(8):1212-1225. doi: 10.4239/wjd.v14.i8.1212.
The occurrence of diabetes mellitus (DM) in pancreatitis is being increasingly recognized lately. Diabetes can develop not only with chronic pancreatitis but even after the first episode of acute pancreatitis (AP). The incidence of diabetes after AP varies from 18% to 23% in 3 years and reaches up to 40% over 5 years. The exact pathogenesis of diabetes after AP is poorly understood and various mechanisms proposed include loss of islet cell mass, AP-induced autoimmunity, and alterations in the insulin incretin axis. Risk factors associated with increased risk of diabetes includes male sex, recurrent attacks of pancreatitis, presence of pancreatic exocrine insufficiency and level of pancreatitic necrosis. Diagnosis of post-pancreatitis DM (PPDM) is often excluded. Treatment includes a trial of oral antidiabetic drugs in mild diabetes. Often, insulin is required in uncontrolled diabetes. Given the lack of awareness of this metabolic disorder after AP, this review will evaluate current information on epidemiology, risk factors, diagnosis and management of PPDM and identify the knowledge gaps.
近年来,胰腺炎患者中糖尿病(DM)的发生越来越受到关注。糖尿病不仅可发生于慢性胰腺炎患者,甚至在急性胰腺炎(AP)首次发作后也可能出现。AP后糖尿病的发病率在3年内为18%至23%,5年后可达40%。AP后糖尿病的确切发病机制尚不清楚,提出的各种机制包括胰岛细胞数量减少、AP诱导的自身免疫以及胰岛素肠促胰素轴的改变。与糖尿病风险增加相关的危险因素包括男性、胰腺炎反复发作、胰腺外分泌功能不全的存在以及胰腺坏死程度。胰腺炎后糖尿病(PPDM)的诊断常常被漏诊。轻度糖尿病的治疗包括试用口服抗糖尿病药物。通常,血糖控制不佳的糖尿病患者需要使用胰岛素。鉴于对AP后这种代谢紊乱缺乏认识,本综述将评估PPDM的流行病学、危险因素、诊断和管理方面的现有信息,并找出知识空白。